| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |